Brooks O'Neil
Stock Analyst at Lake Street
(0.97)
# 3,839
Out of 4,966 analysts
36
Total ratings
32.43%
Success rate
-16.75%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNDM Tandem Diabetes Care | Downgrades: Hold | $75 → $12 | $12.51 | -4.08% | 2 | Aug 11, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $14 → $8 | $4.34 | +84.33% | 7 | Aug 11, 2025 | |
| LFMD LifeMD | Maintains: Buy | $18 → $14 | $6.19 | +126.17% | 3 | Aug 6, 2025 | |
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $8.33 | +140.10% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $34.04 | +26.32% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $95.37 | +15.35% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $18.84 | +59.28% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $29.64 | +139.54% | 1 | Jan 24, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $13.10 | +98.47% | 1 | Dec 19, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $39.00 | +41.03% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $15.90 | +13.21% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $5.15 | -2.91% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $7.10 | +69.01% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $24.73 | +5.14% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.72 | +1,422.07% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $41.64 | +206.20% | 1 | Sep 15, 2020 |
Tandem Diabetes Care
Aug 11, 2025
Downgrades: Hold
Price Target: $75 → $12
Current: $12.51
Upside: -4.08%
AVITA Medical
Aug 11, 2025
Maintains: Buy
Price Target: $14 → $8
Current: $4.34
Upside: +84.33%
LifeMD
Aug 6, 2025
Maintains: Buy
Price Target: $18 → $14
Current: $6.19
Upside: +126.17%
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $8.33
Upside: +140.10%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $34.04
Upside: +26.32%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $95.37
Upside: +15.35%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $18.84
Upside: +59.28%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $29.64
Upside: +139.54%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $13.10
Upside: +98.47%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $39.00
Upside: +41.03%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $15.90
Upside: +13.21%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $5.15
Upside: -2.91%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $7.10
Upside: +69.01%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $24.73
Upside: +5.14%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.72
Upside: +1,422.07%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $41.64
Upside: +206.20%